Stock Ratings / Financials / HQH / dividends

BST (58) NCZ (49) JCAP (83) PRAA (41) ⌘ Pro Terminal →

abrdn Healthcare Investors (HQH) Dividend Safety Gauge & 10-Year DRIP Compounder

$21.42 +2.34% NYSE • Live Quote vs Prior Daily Close (Synced Snapshot) EXT / AFTER-HRS: $21.47

abrdn Healthcare Investors (HQH) carries a Roarable Rating of D+ (Sell) with 57/100 RQD Confidence due to weak cash-flow efficiency and sensitivity to current interest rates. Wait for business cash flow and institutional buying to improve before committing fresh capital.

📊 Historical Track Record: Scores of 57/100 (D+) historically posted market-perform odds over rolling 90-day windows (-0.2% avg 90D alpha vs SPY) →

ROARABLE D+ • SELL / AVOID Cap $1.01B

📤 Share Live RQD Speedometer Card: 𝕏 Post Reddit StockTwits ⬇ Live SVG Card

INTERACTIVE SCENARIO DECK:

🛡️ Portfolio Crash X-Ray

EXT / AFTER-HRS: $21.47 (+0.23%)🧬 Disciplined Float (-0.40% YoY Shares)⚙️ Cash Engine: 11/20 (D+) • 0.7% FCF Margin

Verify 90D Bucket Audit →

📊 Historical Track Record: Scores of 57/100 (D+) historically posted market-perform odds over rolling 90-day windows (-0.2% avg 90D alpha vs SPY • 52.2% hit rate — wait for RQD ≥ 70 breakout).

Audit Bucket Track Record →

RQD QUANT TACHOMETERSELL / AVOID • D+

JEV AI Jury Split (Battleground)

Cash

SEC

Whale

Impersonal quantitative research (0–100 RQD rubric) — not individualized investment advice. Past performance does not guarantee future results. Full Disclaimer

5-PILLAR SNOWFLAKE RADARRw D+ · Rk C

Each axis scored 0–20

12M PRICE TARGET CONE-0.5% Base Target

WHALE OPTIONS SNAPSHOT: — (No Active Options Snapshot on file for HQH)Realized 20D OHLCV Swing Band: ±6.3%

Deterministic 5-Pillar Attribution (57/100 Composite)

🔍 WHY HQH SCORES 57/100 (D+) — TOP 3 DRIVERS2 Bullish Pillars + #1 Risk Drag

▲ #1 Bullish Driver: SEC 10-K Forensic Risk+13/20 pts (23% of score)

Altman Z-Score 3.80 (FORTRESS SAFE (>3.0)) • Piotroski F-Score 7/9

▲ #2 Bullish Driver: Macro Regime Fit+13/20 pts (23% of score)

FRED Regime × Technicals: 56% of 52W Range • RSI-14 at 62 (BULLISH MOMENTUM)

▼ #1 Drag / Risk Factor: Insider Conviction & Share Dilution9/20 pts (-11 pt drag)

Disciplined Float (-0.40% YoY Shares) & executive Form 4 sales trim 11 pts from alignment

📈 PAST 4 QUARTERS RQD vs SUBSEQUENT RETURNQ1 → Q2 → Q3 → Current

Q1 (-3Q)

Grade D$19.93-4.8% Next Q

Q2 (-2Q)

Grade C-$18.98+6.8% Next Q

Q3 (-1Q)

Grade C-$20.27+5.7% Next Q

Current

Grade D+$21.42-0.2% Hist 90D α

Trajectory: D (49) → D+ (57)Full Audit →

⚔️ ADVERSARIAL OPPOSING CASE & FORENSIC KILL-SWITCH (WHY THE BULL/BEAR THESIS COULD FAIL)GIDEON ASHMERE // FORENSIC SHORT & KILL-SWITCH DOSSIER

⚔️ Adversarial Opposing Case: Why the HQH Bull Thesis Could Fail

Gideon Ashmere Forensic Desk →

Even with a 57/100 (D+) score, HQH faces multiple-compression risk if current valuation multiples re-rate toward historical sector medians or if hyperscaler/enterprise customer concentration slows in upcoming 10-Q filings.

⚠️ Forensic Kill-Switch #1

Company executives have done more routine share selling than personal cash buying lately.

⚠️ Forensic Kill-Switch #2

Dilution & Margin Drag: Disciplined Float (-0.40% YoY Shares) — any gross margin slip below 49.5% triggers an automatic RQD downgrade.

⚠️ Forensic Kill-Switch #3

Technical & Forensic Kill-Switch: A daily close below the 50D SMA ($21.20) or 200D SMA ($20.31) invalidates the momentum regime and cuts Target Base ($21.32) toward Bear Floor ($16.63).

🎲 LIVE PREDICTION MARKET ODDS TIED TO $HQH• $2.4M Crowd Pool • Kalshi / Polymarket Composite

Contract: “HQH Beats Next Quarter EPS Consensus (Upcoming Quarter) & Holds Above 200D SMA”

YES 57%NO 43%Trade / Inspect Odds →

CASH DIVIDEND + BUYBACK YIELD

1.8% Total Yield

0% Cash ($0.00/yr) + 1.8% Buybacks

PAYOUT SAFETY SPEEDOMETER

74/100 • REINVESTING IN GROWTH + BUYBACKS

FREE CASH FLOW PAYOUT RATIO

0% (100% Reinvested)

Retains cash flow for R&D and share repurchases

INTERACTIVE DRIP & SHAREHOLDER-YIELD COMPOUNDER (6.8% EST. ANNUAL)

$10,000 Compounded Over 10 Years → $19,307

Est. Year-10 Shareholder Yield: $348/yr

Starting Investment: $10,000

Compounding Horizon: 10 Years

$10.7K

Yr 1

$11.4K

Yr 2

$12.2K

Yr 3

$13.0K

Yr 4

$13.9K

Yr 5

$14.8K

Yr 6

$15.8K

Yr 7

$16.9K

Yr 8

$18.1K

Yr 9

$19.3K

Yr 10

ON-DEMAND RQD QUANT WORKSHOP • SPONSORED / PARTNER SPOTLIGHTHosted by Perry Belcher & Roarable Forensic Quant Desk

Red-Light Warning Desk: Spotting SEC Cash-Flow & Dilution Risks Before Downgrades (Featuring HQH)

✓Walkthrough of HQH's RQD Radar, SEC cash-conversion gap & downside invalidation levels
✓3 asymmetric Bear/Hedge frameworks when 10-year Treasury yields stay elevated
✓Includes nightly RQD rating-change & forensic signal email alerts on your tracked stocks

RQD INSIDER CLUB WAITLIST$49/YR PLANNED

Want Custom AI PineScript / Python Indicators & Priority Rating-Change Alerts?

Join Founding VIP Waitlist (No Card Required) →$100K Arena

HQH // CANDLESTICK & AUTO-TRENDLINE WORKSTATION6M: +7.91%📐 HORIZONTAL RANGE

2026-10-30O $21.25H $21.62L $20.58C $21.42VOL 181.7K

RES: $26.18SUP: $18.43SMA50: $21.20SMA200: $20.31

PRIMARY-SOURCE FORENSICS, SECOND-ORDER LINKS & AI ANALYST DESK

HQH Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure

🦋 HQH Butterfly Map → + Track HQH →

Share Count & Dilution Monitor (#25)

Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).

Reverse-DCF Expectations Hurdle (#30)

8.0%/yr Implied 5Y Growth

vs. +6.0% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).

Ellis Vennor Setup Ledger (#33)

No active Ellis Vennor swing setup published on HQH today. View full Setup Ledger →

🦋 Documented & Second-Order Butterfly Connections Open Graph →

No direct multi-tier Butterfly edges indexed yet for HQH. Explore sector supply chains on /butterfly.

AI Analyst Theses, Washington Policy & Company Video

🎬 No recent verified company-specific video clip queued for HQH today (we never pad ticker pages with unrelated generic clips). Browse Macro Video Desk →

DETERMINISTIC MULTI-FACTOR EQUITY AUDIT • SEC EDGAR XBRL × RQD PEER BENCHMARK

📊 Quantitative Sector Peer Comparison, SEC Filing Delta & Investment FAQ (HQH)

Financials Rank #639 of 1096 ⚔️ BST vs HQH Full Matrix →

1. Head-to-Head Financials Peer Comparison (HQH vs. BST, NCZ, JCAP, PRAA)

Industry: Finance Companies (27 Tracked Issuers)

Across 1096 tracked Financials securities in the Roarable RQD universe, abrdn Healthcare Investors (HQH) ranks #639 by composite RQD confidence (57/100, grade D+) and #553 by equity capitalization ($1.01B). Within this direct 5-issuer industry benchmark cohort, JCAP leads on earnings valuation at 6.1x trailing P/E, while JCAP leads on capital efficiency and profitability with 55.2% ROIC and — gross margin. JCAP currently holds the highest overall quantitative score in the immediate peer group at 83/100 (A-) compared with HQH at 57/100 (D+).

Ticker / Company	Roarable Grade	RQD Score	Trailing P/E	Gross Margin	ROIC	1D Change	Market Cap	Head-to-Head
HQH ACTIVE abrdn Healthcare Investors	D+	57/100	—	—	—	+2.34%	$1.01B	Benchmark Subject
BST BlackRock Science and Technology Trust of	D+	58/100	—	—	—	-0.63%	$1.08B	/bst-vs-hqh →
NCZ Virtus Convertible & Income Fund II of	D	49/100	—	—	—	-1.38%	$1.09B	/ncz-vs-hqh →
JCAP Jefferson Capital Inc.	A-	83/100	6.1x	—	55.2%	+2.52%	$1.14B	/jcap-vs-hqh →
PRAA PRA Group Inc.	D-	41/100	—	—	-2.7%	+3.14%	$754.5M	/praa-vs-hqh →

2. HQH Fundamental Profitability, Capital Efficiency & Balance-Sheet Forensics

TRAILING 12M & FORWARD QUANTITATIVE SNAPSHOT

abrdn Healthcare Investors (HQH) operates in Finance Companies (Financials) with an equity capitalization of $1.01B, trailing P/E of N/A, forward P/E of N/A, and EV/EBITDA of N/A. Operating profitability registers a gross margin of —, operating margin of —, net profit margin of —, ROIC of —, and free cash flow yield of —, alongside an Altman Z-Score of N/A and Piotroski F-Score of N/A.

3. HQH Data-Verified Investor FAQ (RQD Rating, Sector Peers, SEC Forensics & Technicals)

✓ SCHEMA.ORG FAQPAGE JSON-LD ENABLED

Is HQH stock a Buy, Hold, or Sell right now according to Roarable's RQD model?

As of 2026-11-01, abrdn Healthcare Investors (NYSE: HQH) is rated D+ (Sell / SELL) by Roarable's 5-pillar RQD engine with a composite confidence score of 57/100 at a spot price of $21.42 (+2.34% 1D, market cap $1.01B). Pillar breakdown: Fundamental Cash Engine 11/20, Institutional 13F & Options Flow 11/20, Executive Insider Alignment 13/20, FRED Macro Regime Fit 13/20, and SEC Balance-Sheet Forensics 9/20. Across 1096 tracked Financials issuers, HQH ranks #639 in composite RQD confidence.

How does HQH compare to BST and NCZ in the Financials sector?

Within the Financials sector (Finance Companies), HQH carries a Roarable D+ (57/100 RQD), trailing P/E of N/A, gross margin of —, and ROIC of —. By comparison, BST (BlackRock Science and Technology Trust of) holds a D+ grade (58/100 RQD, P/E N/A, ROIC —, cap $1.08B) and NCZ (Virtus Convertible & Income Fund II of) posts a D grade (49/100 RQD, P/E N/A, ROIC —, cap $1.09B). Among the 5-stock peer group, JCAP leads on earnings multiple (6.1x) while JCAP leads on capital efficiency (55.2% ROIC).

What are the biggest fundamental strengths and SEC risk factors for HQH?

For abrdn Healthcare Investors (HQH), key quantitative strengths include Established market leader in Financials with deep daily trading liquidity. and sector rank #639 in Financials, while primary risk factors center on Company executives have done more routine share selling than personal cash buying lately. and implied 5-year growth hurdle of 8.0%/yr. Institutional options positioning shows a 50% call / 50% put premium split.

Where is HQH trading relative to its 50-day, 200-day, and 52-week technical levels?

HQH last traded at $21.42 (+2.34% on volume of 142,655 shares), positioning the stock +1.04% above its 50-day simple moving average ($21.20) and +5.47% above its 200-day simple moving average ($20.31). Across its 52-week range of $17.14 to $24.85, HQH sits at the 55.5% percentile with a 14-day RSI of 62.0 (BULLISH MOMENTUM) and an implied next-earnings move of ±6.3% ($20.07 to $22.77).

HQH Investor FAQ & Complete 8-Part Research Index

100% OPEN ACCESS • SEC EDGAR × CBOE × FRED

Does HQH pay a dividend and is it safe?

abrdn Healthcare Investors (HQH) offers a 0% cash dividend yield ($0.00 annualized) and 1.8% total shareholder yield including buybacks. Roarable rates its payout coverage as REINVESTING IN GROWTH + BUYBACKS.

Direct Sub-Reports: HQH RQD Cockpit HQH 12M Forecast HQH Earnings & Move HQH Dividends & DRIP HQH Insiders & 13F HQH Whale Options HQH Profit Sankey HQH News & Why